Logo image
Glycoproteomic study reveals altered plasma proteins associated with HIV elite suppressors
Journal article   Open access   Peer reviewed

Glycoproteomic study reveals altered plasma proteins associated with HIV elite suppressors

Weiming Yang, Oliver Laeyendecker, Sarah K Wendel, Bai Zhang, Shisheng Sun, Jian-Ying Zhou, Minghui Ao, Richard D Moore, J Brooks Jackson and Hui Zhang
Theranostics, Vol.4(12), pp.1153-1163
2014
DOI: 10.7150/thno.9510
PMCID: PMC4183994
PMID: 25285165
url
https://doi.org/10.7150/thno.9510View
Published (Version of record) Open Access

Abstract

HIV elite suppressors (ES) or controllers are individuals achieving control of viremia by their natural immunological mechanisms without highly active antiretroviral therapy (HAART). Study of the mechanisms responsible for the immunological suppression of viremia in ES may lead to the detection of individuals with ES and the effective control of HIV infection. We hypothesize that plasma glycoproteins play essential roles in the immune system of ES since plasma proteins are critical and highly relevant in anti-viral immunity and most plasma proteins are glycoproteins. To examine glycoproteins associated with ES, plasma samples from ES individuals (n=20), and from individuals on HAART (n=20), with AIDS (n=20), and no HIV infection (n=10) were analyzed by quantitative glycoproteomics. We found that a number of glycoproteins changed between ES versus HAART, AIDS and HIV- individuals. In sharp contrast, the level of plasma glycoproteins in the HAART cohort showed fewer changes compared with AIDS and HIV- individuals. These results showed that although both ES and HAART effectively suppress viremia, ES appeared to profoundly affect immunologically relevant glycoproteins in plasma as consequence of or support for anti-viral immunity. Bioinformatic analysis revealed that altered proteins in ES plasma were mainly associated with inflammation. This analysis suggests that overlapping, while distinguishable, glycoprotein profiles for inflammation and immune activation appeared to be present between ES and non-ES (HAART+AIDS) cohorts, indicating different triggers for inflammation and immune activation between natural and treatment-related viral suppression.
Mass Spectrometry HIV Infections - blood Glycomics HIV Infections - virology Humans Blood Proteins - immunology Male Glycoproteins - blood Blood Proteins - chemistry Antiretroviral Therapy, Highly Active HIV Infections - immunology Glycoproteins - immunology HIV-1 - immunology Adult Anti-HIV Agents - therapeutic use Female HIV Infections - drug therapy Glycoproteins - chemistry Cohort Studies

Details

Metrics

Logo image